Company Overview and News

 
Carnavale Resources gets ready to raise

2017-01-30 proactiveinvestors.com.au
The halt will remain in place until the opening of trade on Wednesday 1st February 2017, or earlier if an announcement is made to the market.

 
Carnavale Resources Ltd drills targeted holes at Lake Roe gold project

2016-10-31 proactiveinvestors.com.au
The tenements area, located 120 kilometres northeast of Kalgoorlie, covers a sequence of deformed Archean greenstone belt within the Southern Laverton Tectonic Zone. The drilling is planned to test anomalous results which occur at the bottom of selected holes along a 600 metres long trend, known as the Stag Prospect. Targeted results include: - 8 metres at 8.22 g/t gold from 79 metres including 1 metres at 57.

 
 
Change in substantial holding

2016-04-20 asx.com.au

 
Appendix 3B - correction

2016-04-11 asx.com.au

 
Change of Address

2016-04-05 asx.com.au

 
Results of Meeting

2016-03-23 asx.com.au

 
Half Year Accounts

2016-03-11 asx.com.au

 
 
Columbus Announces Drill Results Completed by Joint Venture Partner Carnavale Resources at the Red Hills Project in Nevada

2016-02-11 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 11, 2016) - Columbus Gold Corporation (TSX:CGT)(OTCQX:CBGDF) is pleased to announce drill results from its 100% owned Rattler Prospect, Red Hills Project located in eastern Nevada USA, and within the prolific Carlin Trend. Carnavale Resources Limited (ASX:CAV)("Carnavale") has joint venture rights to earn up to...

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

20h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

20h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...